Right heart reverse remodeling: "facta non verba "

Tommaso Recchioni1, Giovanna Manzi1, Alexandra Mihai1

  • 1Department of Clinical, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00161, Rome, Italy.

Summary

Pulmonary arterial hypertension (PAH) treatment aims to reduce pulmonary vascular resistance (PVR) for right heart reverse remodeling (RHRR). Initial triple therapy, including prostanoids, is key to achieving low mortality risk and improving PAH prognosis.